by Jessica Casebolt | May 16, 2023 | M&A, Tea Leaves
The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc’s $27.8 billion deal to buy Horizon Therapeutics PLC. Amgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio. The company...
by Jessica Casebolt | May 2, 2023 | M&A, Tea Leaves
CommonSpirit Health finalized its acquisition of Steward Health Care’s Utah locations, the health systems said Monday. The deal,announced earlier this year, includes more than 35 clinics, imaging and urgent care centers, and five hospitals....
by Jessica Casebolt | Apr 27, 2023 | M&A, Tea Leaves
Kaiser Permanente is acquiring 10-hospital Geisinger Health in a deal described as the first step toward a new multisystem value-based care organization, according to a Wednesday announcement. That new entity, called Risant Health, will be a nonprofit organization...
by Jessica Casebolt | Apr 17, 2023 | M&A, Tea Leaves
Merck & Co. will buy Prometheus Biosciences Inc. for about $10.8 billion to bolster its research pipeline and strengthen its portfolio of autoimmune drugs. The agreement to buy the biotech company, one of the largest pharma deals in recent history, comes as...
by Jessica Casebolt | Apr 4, 2023 | M&A, Tea Leaves
Between 2010 and 2018, 17 percent of unprofitable rural hospitals merged with another organization, while 7 percent closed, according to an analysis from Health Affairs using data from 325 unprofitable hospitals. Of the financially unstable hospitals that didn’t close...
by Jessica Casebolt | Mar 28, 2023 | M&A, Tea Leaves
CVS Health is set to close its major acquisition of health services company Signify Health this week in adeal valued at $8 billion. The acquisition will help advance the health giant’s push into value-based care. It is the latest bid by CVS to get further into health...
Recent Comments